Lilly Warns of Dangerous Impurity in Weight-Loss Compounds
Eli Lilly warns of health risks from compounded weight-loss drugs containing tirzepatide and vitamin B12. An unidentified impurity found in all tested samples poses unknown dangers. The company urges a nationwide recall and has notified the FDA.